Generating Endogenous Myh11-driven Cre Mice for Sex-Independent Gene Deletion in Smooth Muscle Cells
Yang Zhao,Guizhen Zhao,Ziyi Chang,Tianqing Zhu,Ying Zhao,Haocheng Lu,Chao Xue,Thomas L. Saunders,Yanhong Guo,Lin Chang,Y. Eugene Chen,Jifeng Zhang
DOI: https://doi.org/10.1172/jci.insight.171661
IF: 9.4958
2023-01-01
JCI Insight
Abstract:Specific and efficient smooth muscle cell-targeted (SMC-targeted) gene deletion is typically achieved by pairing SMMHC-CreERT2-Tg mice with mice carrying the loxP-flanked gene. However, the transgene, CreERT2, is not controlled by the endogenous Myh11 gene promoter, and the codonmodified iCreERT2 exhibits significant tamoxifen-independent leakage. Furthermore, because the Cre-bearing bacterial artificial chromosome (BAC) is inserted onto the Y chromosome, the SMMHC-CreERT2-Tg mice strain can only exhibit gene deletions in male mice. Additionally, there is a lack of Myh11-driven constitutive Cre mice when tamoxifen usage is a concern. We used CRISPR/ Cas9-mediated homologous recombination between a donor vector carrying the CreNLSP2A or CreERT2-P2A sequence and homologous arm surrounding the translation start site of the Myh11 gene to generate Cre-knockin mice. The P2A sequence enables the simultaneous translation of Cre and endogenous proteins. Using reporter mice, we assessed Cre-mediated recombination efficiency, specificity, tamoxifen-dependent controllability, and functionality in both sexes. Both constitutive sex-independent Cre recombinase activity without confounding endogenous gene expression. mouse models, our models will help expand the research toolbox, facilitating unbiased and comprehensive research in SMCs and SMC-dependent cardiovascular diseases.